AngioDynamics, Inc. (ANGO) Sharpe Ratio: 1.54

ANGO's Sharpe Ratio of 1.54 indicates that for each unit of volatility, it generates 1.54 units of excess return above the risk-free rate. The ratio is calculated using historical daily returns over the past 12 months (as of Aug 1, 2026).

Sharpe uses total volatility (standard deviation) which includes both upside and downside price movements, making it useful for comparing risk-adjusted returns across different assets. For how to read this number and when it can mislead, see Sharpe Ratio Explained.

ANGO Sharpe Ratio Rank

Exceptional

ANGO ranks above 85.7% of all investments in our database based on Sharpe Ratio over the past 12 months, demonstrating exceptional risk-adjusted returns. Securities are ranked from 0 (worst) to 100 (best).

What moves the rank

Strong returns with low total volatility → Higher rank
High volatility (both upside and downside) → Lower rank
Consistent returns → Higher rank than volatile returns of same magnitude
Sharp drawdowns increase volatility → Lower rank

What you can do with this information

Suitable as a core holding given strong risk-adjusted returns
Monitor rank changes to detect deteriorating return-to-volatility profile
Exceptional Sharpe ratio supports larger position sizes
Compare with category peers to assess whether strength is investment-specific or category-wide

ANGO Sharpe Ratio Market Positioning

The chart shows ANGO's Sharpe Ratio relative to all stocks on our platform, with color zones indicating percentile rankings. Higher ratios indicate better risk-adjusted returns.

Red zone (bottom 25%): -0.43 or lower
Yellow zone (middle 50%): -0.43 to 0.98
Green zone (top 25%): 0.98 or higher
Top 1%: 4.27+
Median: 0.14 — half of all investments score higher

How it compares to other similar stocks

The table compares AngioDynamics, Inc.'s Sharpe Ratio with other stocks in the Medical Instruments & Supplies industry across multiple time periods, showing how ANGO's risk-adjusted performance compares to industry peers.

Data shows 1-, 5-, and 10-year periods, plus each stock's all-time average, as of Aug 1, 2026.

Symbol	Name	1Y Sharpe Ratio
AVR	Anteris Technologies Global Corp	1.92
ANGO	AngioDynamics, Inc.	1.54
PLSE	Pulse Biosciences, Inc.	1.54
WST	West Pharmaceutical Services, Inc.	1.28
INFU	InfuSystem Holdings Inc.	1.15
NVST	Envista Holdings Corporation	1.14
BLFS	BioLife Solutions, Inc.	1.04
UTMD	Utah Medical Products, Inc.	1.01
ICUI	ICU Medical, Inc.	0.82
BLCO	Bausch + Lomb Corp	0.80

Benchmark

Compare this symbol against anything

Time Period

How much price history to include in the calculation

Historical Sharpe Ratio

The chart shows ANGO's rolling Sharpe ratio over time compared to your chosen benchmark. Rising trends indicate improving returns relative to total volatility, while declining trends may signal deteriorating risk-adjusted performance or increased volatility. Use multiple timeframes to distinguish short-term fluctuations from long-term patterns.

Identify market cycles by observing when ANGO consistently outperforms (line above benchmark), underperforms (below benchmark), or aligns with the benchmark.

Loading charts...

Sharpe Ratio Calculator

How does ANGO fit in your portfolio?

Add your other holdings to see your portfolio's Sharpe Ratio and find out.

Analyze Your Portfolio